Stop Migraine Pain, Drug-Free
eNeura (eneura.com) scores 68 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, Technology brands, in the 18th percentile of 18989 Healthcare brands.
eNeura is a healthcare technology company headquartered in Baltimore, United States, founded in 2012. It develops sTMS (single-pulse transcranial magnetic stimulation) devices designed to treat migraine without medication. The company positions its product as a clinically proven, drug-free alternative for chronic and episodic migraine sufferers seeking relief without the side effects associated with traditional migraine medications.
| Brand Name | eNeura |
|---|---|
| Domain | eneura.com |
| Industry | Healthcare, Technology |
| Founded | 2012 |
| Headquarters | Baltimore |
| Main Competitors | Cefaly (89/100), Theranica (Nerivio) (77/100), electroCore (gammaCore) (85/100), Neurolief (Relivion) (73/100), Amgen (Aimovig) (90/100), Teva Pharmaceuticals (Ajovy) (86/100) |
Moz Domain Authority 40/100 vs category average 40 / leader 97 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "without Medication Side Effects" (Meta description too short (4 words). OG description present but brief) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on X (Twitter), LinkedIn, Facebook, Instagram, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is eNeura?", Claude could identify the brand as of October 2026. eNeura is a medical device company that makes transcranial magnetic stimulation (TMS) devices for migraine treatment, including the sTMS mini, a portable device patients can use at home to treat and prevent migraine with aura. Best known for FDA-cleared portable TMS devices for migraine relief.
When asked "Best brands similar to eNeura?", Claude would recommend eNeura as of October 2026. It's a notable name in neuromodulation-based migraine treatment, so it's worth mentioning alongside other migraine device or pharma options.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
eNeura's main competitors in Healthcare: Cefaly (89/100), Theranica (Nerivio) (77/100), electroCore (gammaCore) (85/100), Neurolief (Relivion) (73/100), Amgen (Aimovig) (90/100).
Sources: Brand Analyzer scan
eNeura has limited AI-search visibility, scoring 28/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 29, recommendation 38). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: eNeura official site
eNeura was founded in 2012. eNeura operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
eNeura is headquartered in Baltimore. eNeura operates in the Healthcare category.
Sources: Wikidata
eNeura scores 38/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: eNeura official site
eNeura offers an sTMS (single-pulse transcranial magnetic stimulation) device, a smart therapy designed to stop migraine pain without medication. The device is marketed as a clinically proven, drug-free treatment option for both chronic and episodic migraine sufferers.
Sources: eNeura official site
eNeura is a healthcare technology company based in Baltimore, United States, founded in 2012. It specializes in developing medical devices that use single-pulse transcranial magnetic stimulation (sTMS) to treat migraine without the use of medication.
Sources: eNeura official site
eNeura develops and provides an sTMS (single-pulse transcranial magnetic stimulation) device designed to stop migraine pain. The device offers a drug-free therapeutic option intended to provide relief from migraine symptoms without the side effects commonly associated with medication-based treatments.
Sources: eNeura official site
eNeura can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: eNeura official site
eNeura is known for its sTMS device, described as the first and only smart therapy clinically proven to stop migraine pain without medication. The company positions itself as a leading non-drug alternative in migraine treatment, combining clinical evidence with smart technology.
Sources: eNeura official site
eNeura's products are intended for chronic and episodic migraine sufferers who are seeking an effective treatment alternative to medication, particularly those wanting to avoid the side effects associated with drug-based migraine therapies.
Sources: eNeura official site
eNeura scores 28/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
eNeura has a weak AI-visibility profile at 28/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (38/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, a Moz Domain Authority of 40/100 and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify eNeura from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to eNeura: Emson (68/100), Emory University Rollins School of Public Health (68/100), EnoviQ (68/100), Epilepsy Research UK (68/100).
A step up - brands to learn from: Zentralwohlfahrtsstelle der Juden in Deutschland e.V. (71/100), ZT Corporate (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.